Literature DB >> 30607821

Evaluation strategy to determine reliable demyelination in the cuprizone model.

Uta Chrzanowski1, Christoph Schmitz1, Anja Horn-Bochtler2, Anne Nack1, Markus Kipp3,4.   

Abstract

In multiple sclerosis patients, chronic clinical deficits are known to result from axonal degeneration which is triggered by inadequate remyelination. The underlying molecular mechanisms of remyelination and its failure remain currently unclear. In vivo models, among the cuprizone model, are valuable tools to study underlying mechanisms of remyelination and its failure. Since complete and reproducible demyelination of the analyzed brain region is an indispensable prerequisite for efficient remyelination experiments, in this study we systematically addressed which part of the corpus callosum is reliably and consistently demyelinated after acute cuprizone-induced demyelination. Following a novel evaluation strategy, we can show that at the level of the rostral hippocampus, the most medial sectors of the corpus callosum (spanning 500 μm in the horizontal plane) are consistently demyelinated, whereas more lateral sectors show inconsistent and incomplete demyelination. These results precisely define a part of the corpus callosum which should be used as a region of interest during remyelination experiments.

Entities:  

Keywords:  Cuprizone; Demyelination; Optical density; Regeneration; Remyelination

Mesh:

Substances:

Year:  2019        PMID: 30607821     DOI: 10.1007/s11011-018-0375-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  10 in total

1.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

2.  Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.

Authors:  T Schmidt; H Awad; A Slowik; C Beyer; M Kipp; T Clarner
Journal:  J Mol Neurosci       Date:  2012-10-05       Impact factor: 3.444

3.  Remyelination is extensive in a subset of multiple sclerosis patients.

Authors:  Peter Patrikios; Christine Stadelmann; Alexandra Kutzelnigg; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Wolfgang Brück; Claudia Lucchinetti; Hans Lassmann
Journal:  Brain       Date:  2006-08-18       Impact factor: 13.501

4.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

5.  Multiple sclerosis: remyelination of nascent lesions.

Authors:  J W Prineas; R O Barnard; E E Kwon; L R Sharer; E S Cho
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

6.  Quantifying the early stages of remyelination following cuprizone-induced demyelination.

Authors:  Mark F Stidworthy; Stephane Genoud; Ueli Suter; Ned Mantei; Robin J M Franklin
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

7.  Polysialylation at Early Stages of Oligodendrocyte Differentiation Promotes Myelin Repair.

Authors:  Sebastian Werneburg; Hazel L S Fuchs; Iris Albers; Hannelore Burkhardt; Viktoria Gudi; Thomas Skripuletz; Martin Stangel; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  J Neurosci       Date:  2017-07-31       Impact factor: 6.167

8.  PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.

Authors:  Daniele de Paula Faria; Erik F J de Vries; Jurgen W A Sijbesma; Rudi A J O Dierckx; Carlos A Buchpiguel; Sjef Copray
Journal:  Neuroimage       Date:  2013-11-02       Impact factor: 6.556

9.  In Vivo Optical Imaging of Myelination Events in a Myelin Basic Protein Promoter-Driven Luciferase Transgenic Mouse Model.

Authors:  James Cao; Yanping Hu; Mohammed Salman Shazeeb; Carlos E Pedraza; Nilesh Pande; Daniel Weinstock; Gregory H Polites; Wenfei Zhang; Karen J Chandross; Xiaoyou Ying
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

10.  The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.

Authors:  A Slowik; T Schmidt; C Beyer; S Amor; T Clarner; M Kipp
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

  10 in total
  3 in total

1.  Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.

Authors:  Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2019-09-03       Impact factor: 6.600

2.  Endogenous neural stem cells modulate microglia and protect against demyelination.

Authors:  Béatrice Brousse; Océane Mercier; Karine Magalon; Fabrice Daian; Pascale Durbec; Myriam Cayre
Journal:  Stem Cell Reports       Date:  2021-06-03       Impact factor: 7.765

Review 3.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.